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Abstract
Background: MicroRNAs (miRNA) are short nucleotides that interact with their target genes through 3′ untranslated
regions (UTRs). The Cancer Genome Atlas (TCGA) harbors an increasing amount of cancer genome data for both
tumor and normal samples. However, there are few visualization tools focusing on concurrently displaying important
relationships and attributes between miRNAs and mRNAs of both cancer tumor and normal samples. Moreover, a
deep investigation of miRNA-mRNA target and biological relationships across multiple cancer types by integrating
web-based analysis has not been thoroughly conducted.
Results: We developed an interactive visualization tool called MMiRNA-Viewer that can concurrently present the
co-relationships of expression between miRNA-mRNA pairs of both tumor and normal samples into a single graph.
The input file of MMiRNA-Viewer contains the expression information including fold changes between normal and
tumor samples for mRNAs and miRNAs, the correlation between mRNA and miRNA, and the predicted target
relationship by a number of databases. Users can also load their own input data into MMiRNA-Viewer and visualize
and compare detailed information about cancer-related gene expression changes, and also changes in the expression
of transcription-regulating miRNAs.
To validate the MMiRNA-Viewer, eight types of TCGA cancer datasets with both normal and control samples were
selected in this study and three filter steps were applied subsequently. We performed Gene Ontology (GO) analysis for
genes available in final selected 238 pairs and also for genes in the top 5 % (95 percentile) for each of eight cancer
types to report a significant number of genes involved in various biological functions and pathways. We also calculated
various centrality measurement matrices for the largest connected component(s) in each of eight cancers and reported
top genes and miRNAs with high centrality measurements.
Conclusions: With its user-friendly interface, dynamic visualization and advanced queries, we also believe MMiRNA-Viewer
offers an intuitive approach for visualizing and elucidating co-relationships between miRNAs and mRNAs of both tumor
and normal samples. We suggest that miRNA and mRNA pairs with opposite fold changes of their expression and with
inverted correlation values between tumor and normal samples might be most relevant for explaining the decoupling of
mRNAs and their targeting miRNAs in tumor samples for certain cancer types.
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Background
Cancer is a disease caused by an uncontrolled division
of abnormal cells, and it can start from anywhere in
the human body and spread into surrounding tissues/
organs. There are more than 100 types of cancer re-
ported (http://www.cancer.gov/about-cancer/what-is-
cancer). Cancer is affecting millions of lives across the
world. According to the World Cancer Report, cancer
rates could further increase by 50 % to 15 million new
cases in the year 2020 (http://www.who.int/mediacentre/
news/releases/2003/pr27/en/). The leading causes of can-
cer death among men are different from the leading
causes of cancer death among women. Cancer occurrence
also has racial/ethnic and geographic variations (http://
www.cdc.gov/cancer/dcpc/data/).
The advent of next-generation sequencing (NGS) has
opened a new avenue by which, in theory, all of the
limitations of traditional technology can be overcome
at a reasonable cost and the underlying chromosomal
structure of an individual’s DNA can be fully character-
ized down to the nucleotide level. Next-generation
sequencing technology in cancer studies has become an
effective way to provide high sensitivity and resolution
in the post-genomic era.
In 2006, the Cancer Genome Atlas (TCGA), a project
initiated by the National Cancer Institute (NCI) and
National Human Genome Research Institute (NHGRI),
aimed to catalogue mutations responsible for cancer. So
far, more than 30 cancer types and 10 cancer tissues
(Breast, Central Nervous System, Endocrine, Gastrointes-
tinal, Gynecologic, Head and Neck, Hematologic, Skin,
Soft Tissue, Thoracic, Urologic) have been presented for
potential characterization and their DNA and RNA
sequencing data are publicly accessible to the commu-
nity and researchers (http://cancergenome.nih.gov).
The Cancer Genome Atlas project provides various
types of NGS sequencing data including Exome, SNP,
Methylation, mRNA, miRNA, and Clinical. Moreover,
sequencing data for multiple individuals of both tumor
and normal samples are available for each of these
cancer types [1].
MicroRNAs (miRNA) are short nucleotides that interact
with their target genes through 3′ untranslated regions
(UTRs). MicroRNAs can at the same time target many
mRNAs and fine-tune gene expression by means of
cooperative or combinatorial targeting. In other words,
one miRNA can at the same time target many RNAs, and
many miRNAs can cooperatively target a single mRNA
[2]. In mammals, the main effects of the miRNA-mRNA
interaction are the destabilization of the target mRNAs by
the pairing miRNAs [3].
It is common to attempt to describe and/or visualize
miRNA-mRNA interaction networks in order to better
understand their contributions to various diseases states,
including cancer. Generic studies that involve normal
negative correlation have been noticed. In fact, there exist
more complex issues ““decoupling” like genes being either
tumor promoters or suppressors depending on the tumor-
type. The miRNA and mRNA pairs can fail to show nega-
tive correlation when expected, and conversion from
negative to positive correlation. Specifically, a study on
miRNA-mRNA network in brain regions of human alco-
holics suggested that miRNAs would finally overcome the
adaptive upregulation of the targeted genes and resultantly
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turn those initially upregulated alcohol-responsive genes
to be downregulated [2]. The hsa-miR-183 was found to
be expressed higher in most of the breast cancers, but
lower expressed in estrogen receptor-positive breast tu-
mors, which suggests the hsa-miR-183 plays different roles
in different cancer cells [4]. In a study of gastric cancer,
hsa-miR-183 acts as both a tumor promoter (onco-
miRNA) and tumor suppressor miRNA, which depends
on the type and/or subtype of cancer [5].
Furthermore, some pairs of predicted/verified miRNA
and their target mRNA were found to fail to show the
anti-correlation in vivo [6]. The potential mechanisms
by which a target mRNA might “avoid” or become
“uncoupled” from its targeting miRNA was also ex-
plained [7]. The study across multiple TCGA cancer
types by combining all cancers into a global analysis was
performed [8].
We have previously developed a web interface tool
MMiRNA-Tar [9] (http://bioinf1.indstate.edu/MMiRNA-
Tar) that can calculate and plot the correlation of expres-
sion for mRNA-miRNA pairs across samples or over a
time course using a pre-defined correlation cutoff and
prediction confidence. MMiRNA-Tar provides researchers
a convenient tool to calculate the co-relationship between
mRNAs and miRNAs to predict their targeting relation-
ship. In order to facilitate effective interpretation of the
important attributes and values identified for each miRNA
and mRNA pair, in this study we developed a prototype of
the web interface tool MMiRNA-Viewer that can concur-
rently render the co-relationships of mRNA −miRNA
pairs in both tumor and normal samples. We also investi-
gated the target relationship between mRNA and miRNA
pairs for TCGA cancer datasets and studied their bio-
logical functions in a systematic way.
Methods
Overview
The workflow of identifying and selecting both tumor
and normal pairs for eight cancer types is illustrated in
Fig. 1. The details of each step are described below:
Download the matched miRNA and mRNA sequencing
datasets of both tumor and normal samples for available
cancer types from TCGA website
We first downloaded the miRNA and mRNA expression
files for all 34 cancer types from TCGA website. The
expression results were taken from the TCGA Data Level
3. Specifically, miRNA-Seq data were generated by Baylor
College Human Genome Sequencing Center (BCGSC),
and RNA-Seq data were generated by University of North
Carolina at Chapel Hill (UNC). To make measurement
units between two sequencing data sets consistent, we
adopted transcripts per million (TPM) expression values
for both miRNA and mRNA analyses.
Combine all individual samples for both miRNA and
mRNA data for each cancer type
Every sample downloaded from TCGA contains mRNA
and miRNA expression values for individual samples.
We used in-house developed C programs to match
Fig. 1 The workflow of identifying and selecting both tumor and normal pairs for eight cancer types
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patients’ tumor and normal samples in the same sample
order to generate four tabular data files (tumor and
normal each for mRNA and miRNA expression profiles)
for each cancer type.
Calculate correlation values and database prediction
outcomes between miRNA and mRNA pairs
A customized C program was written to calculate Pearson
correlation coefficient (PCC) and check three target pre-
diction databases (TargetProfiler [10], TargetScan [11],
and miRanda [12]) for prediction results of both tumor
and norm samples. When we searched for the match
between pre-miRNA from TCGA and mature miRNA
from target prediction database, we ignored the case and
omitted the last digit (tail). Although miRNA IDs with
different last digits represent the distinct precursor se-
quences, they express identical mature sequence. A match
was also called for compared cases with different lettered
suffixes since they denote closely related mature sequence.
The existence of the targeting relationship was claimed if
a target prediction outcome was supported by at least one
of the three databases mentioned above.
Calculate statistical significance of miRNA and mRNA
correlation pairs
A customized R script was written to perform
normalization and calculate Transcript Per Million
(TPM), Average, Median, P-values and False Discovery
Rate (FDR) values, including multiple testing for miRNA
and mRNA expression files in both tumor and norm
samples. The TPM was calculated for normalized ex-
pression. The average expression was used for calculat-
ing the Fold Change (FC) between tumor and normal
samples. The calculated P-values and FDR values were
used to select statistically significant pairs.
Select cancer types and obtain input miRNA and mRNA
pairs
Among 34 cancer types, 11 cancer types do not have their
normal samples; One cancer type (GBM) has no tumor
sample available; The mRNA and miRNA files in tumor
samples for 7 cancer types do not match their counts.
Two cancer types (STAD and COAD) do not match their
mRNA and miRNA counts in both tumor and normal
samples. There are two cancer types (PAAD and CHOL)
having no common target pairs while selecting opposite
expression pairs. Two cancer types (PCPG and CESC)
were excluded due to the FDR cutoff values (<0.1) that we
employed. The cancer type (THYM) having only two
matched tumor or normal samples was also excluded
from the subsequent analysis. Therefore, we obtained
eight total cancer types (UCEC, KICH, HNSC, THCA,
KIRP, LIHC, LUSC, BLCA) with complete transcriptome
data available for both tumor and normal samples. 29
ambiguous (“?”) genes were excluded because of a similar
reason mentioned in the study [9].
Combine both tumor and normal samples and analyze
differentially expressed mRNAs and miRNAs pairs
between tumor and normal samples
We combined both tumor and normal results by select-
ing miRNA and mRNA pairs with opposite correlation
values and FDR < 0.1 and predicted by at least one of
three prediction algorithms. The FC in terms of expres-
sion ratio of tumor over normal was calculated for miR-
NAs and mRNAs.
Distinguish the proportion of upregulated,
downregulated, and unchanged miRNAs and mRNAs
between tumor and normal samples
In order to compare the regulation directional change
for miRNA and mRNA between tumor and normal sam-
ples within and between cancers, The fraction of upregu-
lated, downregulated, and unchanged for miRNAs and
mRNAs were calculated. The scatter plots of the miR-
NAs in tumor vs in normal and of the mRNAs in tumor
vs in normal for eight cancer types were plotted using a
customized R script.
Determine the importance of mRNAs and miRNAs in
cancer networks
We used various centrality measures (spanning tree,
degree, closeness, betweenness) to identify important
mRNAs and miRNAs in tumor and normal samples for
each of the eight cancers. For degree, closeness, and
betweenness calculation, we used methods described
in the paper [13] and implemented with tnet package
(http://toreopsahl.com/tnet). The calculation of span-
ning tree was done using a modified method described
in the paper [13] and the tools used in implementation
were the octave package for matrix calculation (https://
www.gnu.org/software/octave/).
We first processed all pairs selected for each cancer
type. The connected components (groups) were created
according to the available connection after removing du-
plicated nodes (mRNAs/miRNAs). We only studied the
largest connected component in the analysis. Specific-
ally, for each studied large connected component, edge
lists were generated and tnet package were executed to
calculate degree, closeness, and betweenness centrality.
A customized script was designed to generate adjacency
matrices and calculate Laplacian matrices and determin-
ant of reduced Laplacian matrices. The centrality of
spanning tree was calculated using the overall determin-
ant and the values from Laplacian matrices. The imple-
mentations for the measurement of all centralities were
done using R and customized C programs. All measure-
ment results were normalized using the max values in
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its group. “Nodes” with positive values for most of cen-
trality measurement metrics for each of eight cancers
were selected for cancer annotation.
Annotate cancer association annotation for genes and
miRNAs
We annotated cancer association for gene and miRNA
pairs via querying different databases. Specifically, all the
genes in the table were queried to get annotations of path-
ways using KEGG Mapper – Search Pathway [14], of gene
ontology using Ensembl BioMart [15], of cancer-related
diseases using Catalogue of Somatic Mutations In Cancer
(COSMIC) [16], and of human-related diseases using
Online Mendelian Inheritance In Man (OMIM) [17]. All
the miRNAs were queried to get the experimentally vali-
dated miRNAs and annotations of their related diseases
using DIANA-TarBase [18], Human MicroRNA Disease
Database (HMDD) [19], and miR2Disease [20].
Specifically, in the KEGG Mapper – Search Pathway
[14], the genes in the pairs were entered as objects to
search against ko with all the default parameters. In
the Esembl Biomart [15], the genes in the pairs were
put into the input external references with an ID list
of HGNC symbol(s) to search against the Ensembl
Genes 84 Homo sapiens genes (GRCh38.p5) with all
the default parameters. From the COSMIC website
[16], the Cancer Gene Census file was downloaded
and parsed. From the OMIM website [17], the gene-
map2.txt file was downloaded and parsed. On the
Diana tools TarBase website [18], each miRNA was
searched to get its related diseases. From the HMDD
website [19], the whole dataset of miRNA-disease
association data file was downloaded and parsed. On
the miR2Disease website [20], the “All Entries” file
was downloaded and parsed.
The annotations of genes and experimentally validated
miRNAs from the above-mentioned databases were
manually scrutinized, categorized, and tagged to tell
whether they were related to the eight cancer types in
this study. The annotations that were not related to the
eight cancer types were not included. After the annota-
tion filtering step, each cancer type that the gene and
miRNA pair belongs to were classified into three cat-
egories: the cancer type was found in neither gene nor
miRNA annotations(neither_exist), in either gene or
miRNA annotations (either_exist), and in both gene and
miRNA annotations (both_exist).
Analyze gene functional enrichment for eight cancers
We searched the Database for Annotation, Visualization
and Integrated Discovery (DAVID) [21] for functional
information about smaller sets of genes with their pre-
dicted targeting miRNAs having high correlation values
and reported clusters with enrichment scores greater
than 0.99. We also did ClueGo of Cytoscape plug-in [22]
functional annotation for larger sets of genes which were
selected according to the criteria that pairs’ correlation
values to the top 5 % (95 percentile) in either tumor or
normal samples in each cancer type due to the fact that
the range of correlation values varies substantially
among different cancer datasets.
We also ran ClueGo for a bigger size of gene list. This
set of genes was selected according to the criteria that
pairs’ correlation values to the top 5 % (95 percentile) in
either tumor or normal samples in each cancer type due
to the fact that the range of correlation values varies
substantially among different cancer datasets.
Visualize relationships between miRNA and mRNA pairs
using MMiRNA-Viewer
Only pairs with high confidence (FDR values are less
than 0.1) were uploaded into MMiRNA-Viewer for
visualization. The visualization graph presented by
MMiRNA-Viewer is supported by the Node JS Applica-
tion (D3.js and JQuery: https//d3js.org) with browser
side application prototype. The algorithm for drawing
out the graph starts with the links between mRNA and
miRNA pairs. Links indicate the databases that validated
the connection and normal/tumor correlation. We use
link color intensity to represent the number of predic-
tions by different databases. Then nodes are drawn
based on its type. Basically we use squares to represent
mRNA while circles represent miRNA. Motion actions
like click, drag, and double click are also attached to the
nodes.
The MMiRNA-Viewer can be played using the follow-
ing steps:
1. Upload input miRNA and mRNA pair data. The file
uploaded to the this tool is a text file and should
contain expression correlations between mRNA and
microRNA, mRNA and microRNA normal/tumor
P() and FDR values, Number of Databases that
validated the connection and Normal/Tumor
correlation, and Fold Changes values for miRNA
and mRNA pairs.
2. Search and filter miRNA and mRNA pairs. Users
can search for a specific node in the graph by
inserting the gene name in the search box. After
inputting an mRNA or microRNA name, the user
can click the search button to center its position in
the graph. The ID search is case-sensitive. Addition-
ally, there are various filters that can be applied to
filter data at will. For example, when users select
Node Filter as “mRNA” and Connections Filter as
“>10”, then only the nodes representing mRNA with
connected nodes greater than 10 will be highlighted
in the graph.
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3. Show miRNA and mRNA pair data. Users can click
on two nodes that are connected with each other to
get the annotation values in normal and tumor
samples, which are directly displayed in the table
right below the “Filters”. Users can collapse and
expand the legend on the top right corner in the
graph by clicking the legend icon.
Calculate Pearson Correlation Coefficient (PCC) values
between MMiRNA-Viewer and CrossHub for 100 miRNA
and mRNA pairs in the HNSC tumor data set
To demonstrate merits of the co-relationship for mRNA-
miRNA calculated by MMiRNA-Viewer, we compared our
MMiRNA-Viewer with CrossHub [23], a tool that can also
use the TCGA mRNA RNA-seq data and miRNA-seq data
to calculate the expression correlations between miRNAs
and mRNAs of each cancer type. To do so, we selected
100 unique genes and miRNAs from calculated HNSC_tu-
mor_output data set, which contains 15,870 genes and
398 miRNAs, The shell script “miRNA-Seq-RNA-Seq.co-
expr.sh” in CrossHub.1.3.3 was used to calculate the PCC
values.
Results
miRNA and mRNA data samples
The number of cancer and normal samples downloaded
from TCGA for each cancer type are listed in Table 1.
Significant and inversely correlated miRNA and mRNA
pairs
Upon excluding cancer types that do not have matched
miRNA and mRNA samples and running customized
expression calculation and database prediction scripts,
the filtered expression data for the eight selected cancer
types are generated. We obtained 14,505 total miRNA
and mRNA pairs (both tumor and normal types) which
met the statistical cutoff criteria (inverse correlation
values and FDR < 0.1) for eight cancer types (Additional
file 1). The target prediction results by three selected
databases are shown in Fig. 2. It can be clearly seen that
TargetScan consistently predicts more targeting pairs
than the two other tools. The result indicates that the
target prediction algorithms show similar prediction
trends as in our previous study [9].
Opposite FC miRNA and mRNA pairs
Among 14,505 pairs, we identified 238 pairs meeting the
condition of opposite FC between tumor and normal
samples (Additional file 2). These pairs could be cases
where mRNAs are regulated by miRNAs in opposite
ways. In addition, we found that KICH, KIRP, and HNSC
contain the most number of mRNA-miRNA pairs with
opposite FC values between tumor and normal samples.
On the other hand, LUSC is the cancer with the least
number of pairs with opposite FC values between tumor
and normal samples. We did not find any significant
pairs with mRNA up-regulation (FC > 1) and miRNA
down-regulation (FC < 1) in UCEC (Additional file 3).
Common miRNA and mRNA pairs across cancers
We also compared the number of common mRNA-
miRNA pairs across the eight cancer types. We observed
that the overlapping pairs between cancers are not
Table 1 The number of cancer and normal samples
downloaded from TCGA
Cancer
types
Number of normal
samples
Number of cancer
samples
Total
ACC 0 79 79
BLCA 11 53 64
BRCA 87 776 863
CESC 3 306 309
CHOL 9 36 45
COAD 8 223 231
DBLC 0 47 47
ESCA 11 186 197
FPPP 0 45 45
GBM 5 0 5
HNSC 44 480 524
KICH 25 66 91
KIRC 71 261 332
KIRP 32 291 323
LAML 0 173 173
LGG 0 530 530
LIHC 50 370 420
LUAD 20 455 475
LUSC 38 342 380
MESO 0 87 87
OV 0 299 299
PAAD 4 179 183
PCPG 3 184 187
PRAD 52 498 550
READ 3 91 94
SARC 0 261 261
SKCM 1 450 451
STAD 37 377 414
TGCT 0 156 156
THCA 59 512 571
THYM 2 120 122
UCEC 13 174 187
UCS 0 57 57
UVM 0 80 80
Notes: The bold rows are cancer types selected for the analysis
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Fig. 2 Graphical representations of the predicted miRNA & mRNA relationships by TargetProfiler, TargetScan, and miRanda software. All relationships
shown are mutually exclusive from other groupings. Sizes of rings are relative to the amount of relationships detected by each software tool
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consistent (Table 2). In particular, KIRP and HNSC have
the highest overlap pairs without counting KIRP and
KICH because both are kidney cancer related.
Distribution of upregulated, downregulated, and
unchanged miRNAs and mRNAs between tumor and
normal
In different cancers the ratio of upregulated, downregu-
lated and unchanged miRNAs and mRNAs are different
among cancers (Fig. 3). Especially, the high fraction of
upregulation of miRNAs are constantly accompanied by
the high fraction of downregulation of the mRNAs. The
extreme case is the UCEC, which has all the miRNA
upregulated and all the mRNA downregulated. There are
relatively higher percentages of miRNAs upregulated in
each of the BLCA, HNSC, KIRP, LIHC, LUSC, and UCEC,
whereas there are fewer percentages of miRNAs upregu-
lated in the KICH and THCA. The scatter plot of differen-
tially expressed genes in miRNA and mRNA for all 238
pairs in eight cancers is shown in Additional file 4.
Connections in significant miRNA and mRNA correlation
pair for eight cancers
We obtained connection groups for each selected cancer
and calculated various centrality matrices as mentioned
in the Method section. All selected cancers except LUSC
contain only one connected group with greater than 20
connections/nodes (LUSC: 71; BLCA: 810; HNSC: 2954;
KICH: 926; KIRP: 6109; LIHC: 1264; THCA: 1164;
UCEC: 193). The nodes are selected genes and miRNAs
in the largest group for each cancer. In LUSC’s case,
there are three groups with node size greater than 20. A
connection topology for one of the top clusters with 42
“nodes” in LUSC is shown in Fig. 4.
The centrality scores of genes and miRNAs based on
various matrix measurement for the largest connected
component of eight cancer types were calculated and
shown in Additional file 5.
Cancer association annotation for genes and miRNAs with
positive centrality measurement values
When looking at the gene and miRNA cancer associ-
ation, the results revealed one hit of “both_exist”, 135
hits of “either_exist”, and 102 hits of “neither_exist”.
The both_exist gene and miRNA pair is fibroblast
growth factor receptor 3 (FGFR3) and hsa-miR-100 in
the BLCA. FGFR3 and hsa-miR-100 pair in BLCA have
been identified by this approach and both of them were
reported as the bladder cancer gene and miRNA. In
other words, in the BLCA cancer dataset, the top nega-
tively correlated gene and miRNA in expression values
were both annotated to be related to the cancer BLCA
in the above-mentioned databases. Specifically, FGFR3
gene is reported to be involved in Bladder cancer based
on the result (hsa05219) from the KEGG pathway map-
ping database [14]. Previous studies [24] showed that
the loss of hsa-miR-100 leads to upregulation of FGFR3
before its mutation. Therefore, literature provide the
support that our bioinformatics pipeline can detect
such pairs with the opposite regulation between
mRNAs and miRNAs. Literature search results associ-
ated with cancers for other pairs which are reported
here to have opposite FC values between mRNAs and
miRNAs and inverse correlations between tumor and
normal samples are shown in Additional file 6.
In the nodes of eight cancer types, there are 510 nodes
(Genes/miRNAs) across cancer types, namely appearing
Table 2 The number of common mRNA-miRNA pairs across 8
cancer types
KIRP LIHC UCEC KICH HNSC THCA BLCA LUSC
KIRP - 31 10 49 41 28 6 2
LIHC 31 - 3 3 12 3 1 3
UCEC 10 3 - 0 2 3 3 0
KICH 49 3 0 - 7 4 2 0
HNSC 41 12 2 7 - 11 6 1
THCA 28 3 3 4 11 - 5 1
BLCA 6 1 3 2 6 5 - 0
LUSC 2 3 0 0 1 1 0 -
Fig. 3 The distribution of upregulated, downregulated and
unchanged miRNAs and mRNAs in 238 pairs
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in more than two different cancer types. There is one
gene node across four cancer types.
There are 3 miRNA nodes across 7 cancer types. The
hsa-miR-203 was decreased in esophageal adenocarcinoma
compared to paired adjacent mucosa [25]; the hsa-miR-221
was downregulated in prostate cancer [26]; hsa-miR-222
was upregulated in anaplastic thyroid carcinoma [27].
There are 4 miRNA nodes across 6 cancer types. The hsa-
miR-182 was upregulated in the esophageal cancer [28].
The hsa-miR-183 was upregulated in the metastatic breast
cancer [29]. The hsa-miR-21 was upregulated in the gastric
cancer [30]. The hsa-miR-629 that was functionally inhib-
ited could suppress motility and invasion of the clear cell
renal cell carcinoma [31]. There are 9 miRNA nodes across
5 cancer types. The hsa-miR-106b was downregulated in
the metastatic pancreatic cancer [32]. The hsa-miR-1266
was significantly decreased in expression in gastric cancer
tissues [33]. The has-mir-141 could downregulate the ex-
pression of TM4SF1 to inhibit the pancreatic cancer cells’
migration and invasion [34]. The hsa-miR-145 was down-
regulated in laryngeal squamous cell carcinoma [35]. The
hsa-miR-378 was downregulated in cutaneous squamous
cell carcinoma [36]. The hsa-miR-454 was downregulated
in osteosarcoma [37]. The hsa-miR-484 was upregulated in
expression in the serum samples of early breast cancer
patients [38]. The hsa-miR-625 was upregulated in bile
duct cancer [39]. The hsa-miR-940 was downregulated in
hepatocellular carcinoma tissues and cell lines [40].
Gene functional enrichment analysis
We searched the Database for Annotation, Visualization,
and Integrated Discovery (DAVID) [21] for functional
information about 238 pairs of genes with their pre-
dicted targeting miRNAs at high correlation values. En-
richment of these genes was found in several GO
biological processes. Some of these genes are involved in
protein transport and localization, Some of these genes
are involved in regulation of protein modification
process, some of these genes are associated with
oxidation-reduction, and some genes are involved in
protein modification metabolic process. Genes associ-
ated GO terms from 238 pairs are shown in Table 3.
We used Cytoscape ClueGO plugin to do the GO
enrichment of the 32 files of the top 5 % expression
correlation coefficient of different levels at Normal High
(NH), Normal Low (NL), Tumor High (TH), Tumor
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Fig. 4 The connection topology for one of the top clusters with 42 “nodes” in LUSC
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Low (TL) genes of eight cancers. Only BLCA, HNSC,
KICH, KIRP, LIHC, and THCA have GO enrichment
results. BLCA GO terms were only found in TL dataset,
so we only used HNSC, KICH, KIRP, LIHC, and THCA
to discover GO terms that would be shared by NH and
TL or by NL and TH in each of the five cancers.
The GO terms shared by NH and TL or by NL and
TH in HNSC, KICH, KIRP, LIHC, and THCA were de-
noted by Venn diagrams (Additional file 7). Only HNSC,
KICH, and KIRP had GO terms shared by NH and TL
or by NL and TH. In LIHC and THCA there was no
GO terms shared by NH and TL or by NL and TH. We
found that there were 35 shared GO terms in
HNSC_shared_GO_in_NH_TL, 2 in HNSC_shared_-
GO_in_NL_TH, 41 in KICH_shared_GO_in_NH_TL, 2
in KICH_shared_GO_in_NL_TH, 99 in KIRP_shared_-
GO_in_NH_TL, 47 in KIRP_shared_GO_in_NL_TH, 0
in LIHC_shared_GO_in_NH_TL, 0 in LIHC_shared_-
GO_in_NL_TH, 0 in THCA_shared_GO_in_NH_TL,
and 0 in THCA_shared_GO_in_NL_TH.
It is interesting that the HNSC_shared_GO_in_NH_TL
and KICH_shared_GO_in_NH_TL have many common
GO terms like mitotic sister chromatid segregation,
G1/S transition of mitotic cell cycle, regulation of
transcription involved in G1/S transition of mitotic
cell cycle, and others. HNSC_shared_GO_in_NL_TH
and KICH_shared_GO_in_NL_TH have the exact two
common GO terms, histone deacetylase complex and
positive regulation of transporter activity. These com-
mon GO terms suggest that the HNSC and KICH
cancer have genes of similar functions that interacts
with the miRNA, but the expression correlation coeffi-
cients between these genes and miRNAs are reversed
by both cancers. Genes associated GO terms for these
larger datasets are shown in Additional file 8.
MMiRNA-Viewer
We have developed a prototype visualization tool
-MMiRNA-Viewer with a friendly user interface. Currently
MMiRNA-Viewer supports various types of miRNA-
mRNA co-expression profile data. It also has the function
of filtering various miRNAs and mRNA pairs for better
prediction accuracy. The tool also presents analysis results
in intuitive visualizations and support dynamic uploading
and comparison of files to help users search biological
annotation of customized miRNAs and mRNAs pairs.
Specifically, the graph shows two types of nodes summar-
izing average expression information for mRNAs and
miRNAs, and two types of links representing target rela-
tionships between miRNA and mRNA pairs in normal
and tumor samples. Users can visualize detailed informa-
tion about cancer-related gene expression changes, and
Table 3 Gene Ontology (GO) terms for 238 selected genes
Cancer
Type
GO Term Genes
KIRP,LIHC GO:0000267 ~ cell fraction ABCA3,ADRA1B,DTNA,ENG,FMR1,GPR143,LRP1B,MME,PCSK1N,PDLIM5,PRKCZ,RAPGEF3,SLC26A2,UGT1A1
HNSC,LIHC GO:0001932 ~ regulation of protein
amino acid phosphorylation
CD3E,ENG,FGF2,PRKCZ,RAPGEF3
KIRP,LIHC GO:0005624 ~membrane fraction ABCA3,ADRA1B,DTNA,ENG,GPR143,LRP1B,MME,PDLIM5,PRKCZ,RAPGEF3,SLC26A2,UGT1A1
KIRP,LIHC GO:0005626 ~ insoluble fraction ABCA3,ADRA1B,DTNA,ENG,GPR143,LRP1B,MME,PDLIM5,PRKCZ,RAPGEF3,SLC26A2,UGT1A1
BLCA,KICH GO:0005856 ~ cytoskeleton ABI2,CDC14A,ESPL1,KIF13B,MYO5B,NAV1,PDLIM2,PDLIM5,PKD2,SGCE,TUBE1
BLCA,THCA GO:0005886 ~ plasma membrane ABI2,AGPAT1,ANTXR1,FGFR3,NBEA,PARVA,PIK3C2A,SGCE,SVIL
HNSC,LIHC GO:0019220 ~ regulation of
phosphate metabolic process
ADCY4,CD3E,ENG,FGF2,PRKCZ,RAPGEF3
BLCA,KICH GO:0019899 ~ enzyme binding ABI2,ATN1,KIF13B,NBEA,PDLIM5,PKD2,RAD18
HNSC,LIHC GO:0031399 ~ regulation of protein
modification process
CD3E,ENG,FGF2,NDFIP2,PRKCZ,RAPGEF3
HNSC,LIHC GO:0032268 ~ regulation of cellular
protein metabolic process
CD3E,EIF2C3,ENG,FGF2,NDFIP2,PRKCZ,RAPGEF3
HNSC,LIHC GO:0042325 ~ regulation of
phosphorylation
ADCY4,CD3E,ENG,FGF2,PRKCZ,RAPGEF3
BLCA,KICH GO:0043228 ~ non-membrane-
bounded organelle
ABI2,CDC14A,ESPL1,KIF13B,MYO5B,NAV1,PDLIM2,PDLIM5,PKD2,RAD18,SGCE,TUBE1
BLCA,KICH GO:0043232 ~ intracellular non-
membrane-bounded organelle
ABI2,CDC14A,ESPL1,KIF13B,MYO5B,NAV1,PDLIM2,PDLIM5,PKD2,RAD18,SGCE,TUBE1
HNSC,LIHC GO:0051174 ~ regulation of
phosphorus metabolic process
ADCY4,CD3E,ENG,FGF2,PRKCZ,RAPGEF3
KIRP,LIHC GO:0055114 ~ oxidation reduction AKR7A2,GRHPR,HSD17B1,IVD,MOSC2,OGFOD1,RETSAT,SC5DL
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also changes in the expression of transcription-regulating
miRNAs for well-characterized cancer genomes. Users
can also drag nodes and their associated partners to iso-
lated positions for better visualization. This can help users
to better study the interaction relationships of a miRNA
and mRNA pair and can make a node-link diagram more
suitable for publication. Moreover, with displayable gene/
miRNA labeling for each node, users can capture the
screenshots of some sub-networks for their publications.
Not only does MMiRNA-Viewer allow for the viewing of a
single sample’s mRNA miRNA pairs, but this tool also has
the functionality to display pairs in common between two
separate files (e.g. customized input file vs built-in TCGA
datasets). An interface screenshot of MMiRNA-Viewer is
shown in Fig. 5.
MMiRNA-Viewer is available at http://bioinf1.indsta-
te.edu/MMiRNA-Viewer.
Comparison of Pearson Correlation Coefficient (PCC)
values between MMiRNA-Viewer and CrossHub for 100
miRNA and mRNA pairs
When compared to a short running time (less than one
minute) using MMiRNA-Viewer, it took CrossHub 9 min
to calculate correlation coefficient values for 1836 pairs.
The average value of absolute difference between two
methods is ~0.07. The calculated correlation values by
two methods are shown in Additional file 9.
Discussions
In this study, we developed a web-based tool MMiRNA-
Viewer to upload input data files and visualize the results
in an intuitive way that user can quickly locate their
interested pairs for further functional study. The current
version has many interesting features, but its functional-
ities can be further expanded. For instance, we would
like to incorporate other functionalities with publicly
available literature search and pathways mapping study.
Our study assumed that the tumor is activated via
mRNAs mutation directly targeted by miRNAs. Results
that miRNAs and mRNAs are inversely correlated exist
in 238 selected pairs for eight studied cancers. Our
protocol that inversely correlated miRNA and mRNA
pairs should be oppositely regulated in tumor samples
could be useful for prioritizing cancer associated pairs.
Current example input files for MMiRNA-Viewer were
generated using TCGA cancer sequencing data (Level 3)
to compute the correlation coefficients and target rela-
tionships for miRNA and mRNA pairs between tumor
and normal samples using three state-of-art database
prediction algorithms. We took FDR cutoff (<0.1) to
select significantly correlated miRNA and mRNA pairs
in the initial step so that more pairs potentially associ-
ated with cancers through inverse correlation could be
included. Under the assumption that miRNA and mRNA
pairs are often inversely correlated and their FC values
should be opposite between tumor and normal samples,
we obtained 238 pairs for GO biological function and
pathway studies.
We employed a modified spanning tree centrality
method for calculation. We have found that due to
the definition of spanning tree, some nodes have pre-
determined values of simply 1 and 0 and thus are not
Fig. 5 An interface screenshot of MMiRNA-Viewer
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very interesting and can be predicted. This does help
to calculate the result easier as we can remove some
nodes and still generate the exact results for all nodes
that cannot be predicted, thus increasing speed and
precision of the calculation. We can then go back
and fill in or modify the predictable values. Further,
we have introduced a method to modify the value of
the 1 s to better reflect their actual centrality while
still using the spanning tree method as a back bone.
For KIRP cluster, we used an altered approach for the
calculation of spanning tree due to the large number
of connections in the cluster. Specifically, the algo-
rithm first found the most distant point from each
“node” (gene or miRNA), then broke the nodes into
two groups and removed branches from each two
halves to calculate adjusted spanning tree values.
Finally, two sets of results were merged according to
original connections to report final spanning tree
values.
Unlike our algorithm that filters out the pairs using
P-values and FDR of the calculated correlation coeffi-
cients and using the above-mentioned 3-database
matching, CrossHub, doesn’t filter out the calculated
correlation coefficients of miRNAs and mRNAs via
their reported P-values, via unreported FDR of their
correlation coefficients, and via their reported miRNA-
mRNA targeting databases. The two programs are
basically consistent with respect to the calculation of
the expression correlation coefficients of the miRNA-
mRNA in the same dataset (HNSC) in TCGA. The
slight difference of calculated correlation coefficient values
might be due to the fact that CrossHub adopted read
number mapped to each genes, whereas MMiRNA-Viewer
uses TPM, so the mapping process might cause differences.
In CrossHub pipeline, “By default, CrossHub performs the
analysis for top 30 overexpressed microRNA with read
counts (across all the samples) from 20,000 to 4,000,000.
These miRNA represent the most important fraction in
the context of biological regulation”. In addition, the
memory usage of CrossHub is huge and running time is
quite long.
Conclusions
We developed an intuitive graph visualization tool
MMiRNA-Viewer that provides a user interface for vari-
ous cancer types of miRNA-mRNA expression data with
significant interaction pairs. Our MMiRNA-Viewer sup-
ports dynamic queries through intuitive user interactions
to help users search meaningful cancer biological find-
ings. We also suggested that miRNA and mRNA pairs
with opposite FC values of their expression and with
inverted correlation values between tumor and normal
samples might be potential pairs to be responsible for
transcription decoupling for certain cancer types.
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